1 | New
Developments in the Pathobiology of Prostate Disease | J.
Schalken (NL). |
2 | Advances
in Biomarkers for Prostate Disease | R.
Getzenberg (USA) |
3 | Epidemiology
and Natural History of Prostate Disease | M.
Barry (USA) |
4 | New
Development in Imaging of the Prostate and Metastatic Sites | M.
Resnick (USA) |
5 | LUTS:
Etiology and Patient Assessment | P.
Abrams (UK) |
6 | New
Medical Developments in the Management of LUTS in Adult Men | C.
Chapple (UK) |
7 | New
Minimally-Invasive and Surgical Developments in the management of BPO
| J.
de la Rosette (NL) |
8 | Prevention
of BPH Outcomes and Clinical Progression | C.
Roehrborn (USA) |
9 | New
Therapeutic Targets in BPH and LUTS (Research Priorities) | K-E.
Andersson (E) |
10 | New
Developments in Screening and early Detection for Prostate Cancer | F.
Schroeder (NL) |
| 11 | Prostate
Cancer Chemoprevention | P.
Gan (USA) |
| 12 | New
Developments in the Treatment of Localized Prostate Cancer | F.
Schroeder (NL) |
| 13 | New
Therapeutic Targets and Treatments for Metastatic Prostate Cancer | W.
Nelson (USA) |
| 14 | Androgen
Replacement Therapy in Men at Risk for Prostate Disease | C.L
Schulman (Belgium) |
| 15 | Prostatitis
and Chronic Pelvic Pain | T.
Schaeffer (USA) |
| 16 | Patient’s
Perspectives in Prostate Diseases | T.
Hudson (E) |
| | History
of Prostatic Diseases | D.
Schultheiss-R. Waldbaum |
